Merck & Co., (MRK) Financials
Merck & Co., (MRK) Historical Financial Statements and Key Metrics for 1994 - 2025
Full Merck & Co., financials for 1994 - 2025 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Merck & Co., Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2025-Sep-30 | 17,276 | 14,152 (81.9 %) | 7,556 (43.7 %) | 5,785 (33.5 %) | 8,137 | 2.32 |
| 2025-Jun-30 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2025-Mar-31 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2024-Dec-31 | 15,624 | 14,700 (94.1 %) | 6,820 (43.7 %) | 3,743 (24.0 %) | 6,929 | 1.49 |
| 2024-Sep-30 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2024-Jun-30 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2024-Mar-31 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
Full historical income statements for 1994 - 2025 is included in the
US Historical Financials dataset.
Merck & Co., Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2025-Sep-30 | 129,546 | 77,639 | 41,374 | 51,850 | 18,214 |
| 2025-Jun-30 | 117,523 | 68,463 | 35,402 | 48,993 | 8,622 |
| 2025-Mar-31 | 115,122 | 66,722 | 34,844 | 48,335 | 9,228 |
| 2024-Dec-31 | 117,106 | 70,734 | 37,111 | 46,313 | 13,689 |
| 2024-Sep-30 | 117,532 | 72,972 | 38,131 | 44,502 | 14,593 |
| 2024-Jun-30 | 112,630 | 68,982 | 37,788 | 43,582 | 11,396 |
| 2024-Mar-31 | 105,849 | 65,425 | 34,219 | 40,364 | 5,711 |
Full historical balance sheet data for 1994 - 2025 is included in the
US Historical Financials dataset.
Merck & Co., Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2025-Sep-30 | 7,822 | -283 | 2,638 | 6,835 |
| 2025-Jun-30 | 3,293 | -770 | -3,556 | 2,529 |
| 2025-Mar-31 | 2,500 | -1,487 | -5,755 | 1,172 |
| 2024-Dec-31 | 3,450 | -1,444 | -3,009 | 2,513 |
| 2024-Sep-30 | 9,291 | -3,845 | -2,425 | 8,508 |
| 2024-Jun-30 | 5,637 | -1,069 | 1,216 | 4,846 |
| 2024-Mar-31 | 3,090 | -1,376 | -2,814 | 2,229 |
Full historical cash flow data for 1994 - 2025 is included in the
US Historical Financials dataset.
Merck & Co., Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2025-Sep-30 | 209,657 | 232,862 | 12.14 | 9.06 | 4.04 |
| 2025-Jun-30 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2025-Mar-31 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2024-Dec-31 | 252,779 | 276,648 | 16.18 | 16.88 | 5.46 |
| 2024-Sep-30 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2024-Jun-30 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2024-Mar-31 | 0 | 0 | 0.00 | 0.00 | 0.00 |
Full historical valuation and operating metrics for 1994 - 2025 are included in the
US Historical Financials dataset.